Target Biology: WASF1 and the Actin Cytoskeleton

WASF1, also known as WAVE1, is a founding member of the WASP/WAVE family of scaffold proteins that link extracellular signals to actin cytoskeleton remodeling. WASF1 functions within the pentameric WAVE Regulatory Complex (WRC) alongside ABI1/2, HSPC300, NAP1, and PIR121/CYFIP, acting as a downstream effector of the small GTPase Rac1.

Upon activation, WASF1 stimulates the Arp2/3 complex to nucleate branched actin filaments, driving lamellipodia formation, cell migration, neuronal morphogenesis, and immune cell function. Dysregulation of WASF1 has been implicated in cancer invasion, metastasis, and neurodevelopmental disorders, making it a biologically and clinically relevant research target.

Review flag: Specific pathway citations (e.g., Rac1–WRC–Arp2/3 axis) are well-established textbook knowledge; however, researchers should consult primary literature for the most current understanding of WASF1 isoform-specific functions.

Antibody Specifications and Quality Considerations

The WASF1 Mouse mAb (Ab350819) is produced using standard murine hybridoma technology, providing the high epitope specificity and batch-to-batch consistency characteristic of monoclonal antibodies. Key product attributes include:

• Host / Isotype: Mouse monoclonal; isotype should be confirmed on the product datasheet prior to use in isotype-control experiments.
• Formulation: Supplied in PBS only (no carrier protein, no azide indicated in source material). Researchers requiring long-term storage stability should consider aliquoting upon receipt and storing at –20 °C.
• Clone: KC-46627 (absea). Cross-referencing this clone against published literature can help identify validated applications and species cross-reactivity data.
• Concentration: Refer to the certificate of analysis (CoA) supplied with each lot for exact protein concentration and purity data.

Review flag: Isotype, exact concentration, and species reactivity are not specified in the supplied source material. These must be verified on the official product datasheet or CoA before experimental use.

Recommended Application Protocols

While specific validated applications must be confirmed on the product datasheet, WASF1 monoclonal antibodies are commonly used across the following immunoassay platforms. The guidelines below reflect standard best practices:

Western Blot (WB)

1. Prepare total cell lysate or tissue homogenate in RIPA buffer supplemented with protease inhibitors.
2. Resolve 20–40 µg protein by SDS-PAGE (10–12% gel) and transfer to PVDF membrane.
3. Block with 5% non-fat dry milk or 3% BSA in TBST for 1 hour at room temperature.
4. Incubate with WASF1 Mouse mAb at an empirically optimized dilution (typically 1:500–1:2000) overnight at 4 °C.
5. Wash 3× with TBST, then incubate with HRP-conjugated anti-mouse secondary antibody (1:5000–1:10000) for 1 hour at room temperature.
6. Detect using ECL substrate. Expected band: ~65 kDa for WASF1.

Immunohistochemistry (IHC)

1. Mount formalin-fixed, paraffin-embedded (FFPE) sections (4 µm) on positively charged slides.
2. Perform deparaffinization, rehydration, and antigen retrieval (citrate buffer pH 6.0 or EDTA buffer pH 9.0).
3. Block endogenous peroxidase and non-specific binding.
4. Apply primary antibody at optimized dilution; incubate overnight at 4 °C in a humidified chamber.
5. Apply species-appropriate HRP-conjugated secondary antibody and DAB chromogen.
6. Counterstain with hematoxylin, dehydrate, and mount.

Review flag: Exact validated dilutions, species reactivity, and confirmed application list for Ab350819 are not present in the source material. All dilutions listed are general guidance. Confirm with the official datasheet or by empirical titration.

Storage, Handling, and Troubleshooting

Storage Recommendations:

• Store the antibody at –20 °C upon receipt for long-term stability.
• For short-term use (up to 1–2 weeks), aliquots may be kept at 4 °C.
• Avoid repeated freeze–thaw cycles, which can reduce antibody activity and lead to aggregate formation. Prepare single-use aliquots after the first thaw.
• The PBS-only formulation (no preservative indicated) requires aseptic handling to prevent microbial contamination.

Common Troubleshooting Issues:

Review flag: Troubleshooting guidance is based on general monoclonal antibody best practices. Application-specific validated conditions for Ab350819 should be confirmed via the Aladdin Scientific product datasheet.

Experimental Controls and Validation Checklist

Rigorous antibody validation is essential for reproducible results. The following checklist is recommended for first-time users of WASF1 Mouse mAb (Ab350819):

1. Positive Control: Use a cell line or tissue known to express WASF1 (e.g., neuronal cell lines or tissues where WAVE1 expression is documented in the literature).
2. Negative Control: Include a sample from WASF1-knockout cells or a non-expressing tissue, if available.
3. Isotype Control: Run a parallel experiment with a mouse IgG isotype control at the same concentration to assess non-specific binding.
4. Secondary-Only Control: Omit the primary antibody in one sample to detect secondary antibody background.
5. Loading / Expression Normalization (WB): Co-probe with a housekeeping protein antibody (e.g., β-actin, GAPDH) to confirm equal loading.
6. Lot-to-Lot Consistency: When transitioning to a new antibody lot, run side-by-side comparisons with the previous lot on the same positive control lysate.

Review flag: Specific WASF1-positive cell line recommendations should be verified against current literature, as expression profiles can vary by passage number and culture conditions.